ArticleJournal of pharmaceutical policy and practice2018
A bibliometric analysis of the global research on biosimilars.
Article in Journal of pharmaceutical policy and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Stakeholder experience with artificial intelligence in healthcare: a bibliometric study of satisfaction, trust, acceptance, and patient engagement.Frontiers in digital health · 2026Pooled it
- Advances in Biosimilars: A Systematic Review of Machine Learning Applications.Pharmaceuticals (Basel, Switzerland) · 2026Review
- An Exploratory Bibliometric Analysis of African Pharmacovigilance Research Output Using SCOPUS.Cureus · 2024Review
- Global research trends in the microbiome related to irritable bowel syndrome: A bibliometric and visualized study.World journal of gastroenterology · 2021Article
- Landscape of research, production, and regulation in venoms and antivenoms: a bibliometric analysis.Revista panamericana de salud publica = Pan American journal of public health · 2021Article
- Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak.BMC infectious diseases · 2020Article
- Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study.BMC gastroenterology · 2019Article
- Global scientific trends on aflatoxin research during 1998-2017: a bibliometric and visualized study.Journal of occupational medicine and toxicology (London, England) · 2019Article
- Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis.Frontiers in pharmacology · 2019Article
- Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars.Journal of pharmaceutical policy and practice · 2018Article
- Research onF1000Research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBiosimilars could be a promising option to help decrease healthcare costs and expand access to treatment. There is no previous evidence of a global bibliometric analysis on biosimilars. Therefore, we aimed to assess the quantity and quality of worldwide biosimilars research.
methodsWe performed a bibliometric analysis using documents about biosimilars published until December 2016 in journals indexed in Scopus. We extracted the annual research, languages, countries, journals, authors, institutions, citation frequency, and the metrics of journals. The data were quantitatively and qualitatively analyzed using Microsoft Excel 2013. Additional information about authors' participation was obtained using the R-package Bibliometrix. Publication activity was adjusted for the countries by population size. Also, author co-citation analysis and a term co-occurrence analysis with the terms included in the title and abstract of publications was presented as network visualization maps using VOSviewer.
resultsA total of 2330 biosimilar-related documents identified in the Scopus database, most of them were articles (1452; 62.32%). The number of documents published had an exponential increased between 2004 and 2016 (
conclusionsResearch production and publication of documents on biosimilars are increasing. The majority of publications came from high-income countries. The trends in terminology use are according to state of the art in the topic, and reflects the interest in the utilization of biosimilars in diseases who are expected to obtain benefits of its use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.